Insider · CIK 0002055339
Karim Galzahr
Files at OSTX (OS Therapies Inc). First filing -, latest -.
Karim Galzahr files SEC Form 4 as director at OSTX (OS Therapies Inc). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Karim Galzahr has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jan 22, 2026 | OSTX OS Therapies Inc | AGrant or award Stock options (right to buy)derivative | +50,000 | $0.00 | $0 | 50,000 | Feb 13, 2026 |
| Oct 21, 2025 | OSTX OS Therapies Inc | AGrant or award Stock options (right to buy)derivative | +140,000 | $0.00 | $0 | 140,000 | Dec 19, 2025 |
Questions about Karim Galzahr
Answered from the filings on this page, as of the latest one.
Is Karim Galzahr buying or selling?
Karim Galzahr has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Karim Galzahr's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Karim Galzahr has 0.
Where does Karim Galzahr file Form 4?
Karim Galzahr has filed Form 4 at OSTX (OS Therapies Inc). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.